  |
"We sit on the brink of unparalleled opportunities in the healthcare and
life sciences fields. Three major forces are coming together: the accelerating
pace of scientific innovation, an aging population, and an unprecedented
interest in entrepreneurship. Inevitably, these will combine to cause great
companies to emerge."
Bob has more than twenty-five years of experience in venture capital and has served as a director of many public and private companies. He is a former director of the National Venture Capital Association and President of the New England Venture Capital Association. In addition, Bob has been recognized by the prestigious Forbes Midas List as one of the top venture capitalists in the industry. Background Bob has been an investor in many successful healthcare service, medical device and biotechnology companies. Some of the services companies he has backed are Community Health Systems (NYSE: CYH), Mariner Health Group (IPO/acquired), New England Critical Care (IPO/acquired), Renal Treatment Centers (IPO/acquired) and U.S. Labs (acquired). Bob's medical technology investments include AVEO Pharmaceuticals, Codon Devices, Conor Medsystems (IPO/acquired), Helicos BioSciences (Nasdaq: HLCS), Magen BioSciences, Mitotix (Neuer Market: GPC Biotech AG), Origin Medsystems (acquired), PerSeptive Biosystems (IPO/acquired), Pervasis Therapeutics, PRAECIS PHARMACEUTICALS (Nasdaq: PRCS) and RedBrick Health. In addition, Bob has also served on the boards of Staples.com and WordWave (acquired by Merrill Corporation). Before co-founding Highland, Bob was a general partner at a Boston-based venture capital partnership. Immediately prior to entering venture capital, he spent four years as the Executive Director of the John A. Hartford Foundation. He also was the Chief Executive of the Clark Foundation and the Burden Foundation. Bob is a former Assistant to the U.S. Secretary of Commerce and an Assistant to the head of the international division of the U.S. Treasury. Education Harvard College, A.B., History Harvard Business School, M.B.A. Interests Bob is involved in many activities related to venture capital and healthcare. Currently, he is a member of the Advisory Board of the Department of Health Care Policy at Harvard Medical School and the Advisory Board of the Harvard - MIT Division of Health Sciences & Technology. Also, Bob has been a faculty member at the Harvard Business School since 2001. At HBS, he currently teaches a second year course called Entrepreneurship and Venture Capital in Healthcare. |
